StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

4-Hydroxynonenal

HCID 5283344
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
128946-65-6
Standard-SMILES
CCCCCC(O)/C=C/C=O
InChIKey
JVJFIQYAHPMBBX-FNORWQNLSA-N
Summenformel
C9H16O2
Durchschnittliche Molmasse
156,22 g/mol
Monoisotopische Masse
156,11502975

Überblick

4-hydroxynon-2-enal is an enal consisting of non-2-ene having an oxo group at the 1-position and a hydroxy group at the 4-position. It has a role as a human metabolite. It is a 4-hydroxynonenal, a hydroxyaldehyde and an enal.

Namen und Bezeichner

Bevorzugter Name
4-Hydroxynonenal
IUPAC
(E)-4-hydroxynon-2-enal
Englischer Name
HNE
Summenformel
C9H16O2
Molmasse
156.22

Namen und Synonyme

4-Hydroxynonenal75899-68-24-Hydroxy-2-nonenal4-HNE4-Hydroxy-2,3-nonenal(2E)-4-hydroxynon-2-enalK1CVM13F964-hydroxynonen-2-al4-HNE cpdRefChem:912599CHEBI:142593(E)-4-hydroxynon-2-enal
Weitere Namen anzeigen
HNECcris 17814-hydroxy-2-nonena(E)-4-HYDROXYNONENAL(±)4-Hydroxynon-2-enal4-HNE/4-Hydroxynonenal
trans-4-Hydroxy-2-nonenal(E)-4-hydroxy-2-nonenal(2E)-4-Hydroxy-2-nonenal128946-65-62-Nonenal, 4-hydroxy-, (2E)-4-hydroxy-2E-nonenalDTXSID40403952-NONENAL, 4-HYDROXY-

Datenbank-Bezeichner

CAS
128946-65-6、29343-52-0、75899-68-2
PubChem CID
5283344
DTXSID
DTXSID4040395
ChEMBL
CHEMBL454280
ChEBI
CHEBI:32585
UNII
K1CVM13F96
Nikkaji
J34.593H、J356.016C

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
1,7
Polarare Oberfläche (TPSA)
37,3 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
2
Frei drehbare Bindungen
6
Schwere Atome
11
Formalladung
0
Komplexität
119

Experimentelle und physikochemische Eigenschaften

LipidsFatty Acyls [FA] -> Fatty aldehydes [FA06]
Physical DescriptionSolid

Physikochemische Eigenschaften

Siedepunkt
125 · 125-127 °C(Press: 2 Torr)
Dichte
0.941 · 0.941±0.06 g/cm3(Predicted)
storage temp.
-70 °C · -70°C
Löslichkeit
50 mg/ml; · DMF: >50 mg/ml; DMSO: >50 mg/ml; Ethanol: >50 mg/ml; PBS pH 7.2: >1 mg/ml
pka
13.31 · 13.31±0.20(Predicted)
Aggregatzustand
Colorless oil.
Farbe
Colorless to light yellow
InChI
InChI=1S/C9H16O2/c1-2-3-4-6-9(11)7-5-8-10/h5,7-9,11H,2-4,6H2,1H3/b7-5+
InChIKey
JVJFIQYAHPMBBX-FNORWQNLSA-N
SMILES
C(=O)/C=C/C(O)CCCCC

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

Toxikologische Informationen

TreatmentKidney dialysis is usually needed to relieve the symptoms of uremic syndrome until normal kidney function can be restored.
Health EffectsChronic exposure to uremic toxins can lead to a number of conditions including renal damage, chronic kidney disease and cardiovascular disease.
Exposure RoutesEndogenous, Ingestion, Dermal (contact)
Toxicity Summary · 1 Eintrag

Uremic toxins such as 4-Hydroxynonenal are actively transported into the kidneys via organic ion transporters (especially OAT3). Increased levels of uremic toxins can stimulate the production of reactive oxygen species. This seems to be mediated by the direct binding or inhibition by uremic toxins of the enzyme NADPH oxidase (especially NOX4 which is abundant in the kidneys and heart) (A7868). Reactive oxygen species can induce several different DNA methyltransferases (DNMTs) which are involved in the silencing of a protein known as KLOTHO. KLOTHO has been identified as having important roles in anti-aging, mineral metabolism, and vitamin D metabolism. A number of studies have indicated that KLOTHO mRNA and protein levels are reduced during acute or chronic kidney diseases in response to high local levels of reactive oxygen species (A7869).

Signs and Symptoms · 1 Eintrag

As a uremic toxin, this compound can cause uremic syndrome. Uremic syndrome may affect any part of the body and can cause nausea, vomiting, loss of appetite, and weight loss. It can also cause changes in mental status, such as confusion, reduced awareness, agitation, psychosis, seizures, and coma. Abnormal bleeding, such as bleeding spontaneously or profusely from a very minor injury can also occur. Heart problems, such as an irregular heartbeat, inflammation in the sac that surrounds the heart (pericarditis), and increased pressure on the heart can be seen in patients with uremic syndrome. Shortness of breath from fluid buildup in the space between the lungs and the chest wall (pleural effusion) can also be present.

Chemie und Industrie

Pharmakologische Informationen

Metabolism/MetabolitesUremic toxins tend to accumulate in the blood either through dietary excess or through poor filtration by the kidneys. Most uremic toxins are metabolic waste products and are normally excreted in the urine or feces.
MeSH Pharmacological Classification · 2 Einträge

Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other.

Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES.

Cellular LocationsExtracellular

Verwendung und Herstellung

UsesNaturally produced by the body (endogenous).
Anwendungen · 1 Eintrag

VerwendenHNE is a lipid peroxidation product derived from oxidized ω-6 polyunsaturated fatty acids such as arachidonic acid. 4-hydroxy Nonenal is widely used as a marker of lipid peroxidation. It exhibits various biological activities such as cytotoxicity, growth inhibiting activity, genotoxicity, and chemotactic activity. HNE inhibits pro-oxidant-induced Ca2+ release from mitochondria at 10-50 μM.[Cayman Chemical]

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

2,3-EPOXYOCTANAL2-Nonen-4-ol, 1-bromo-, (2E)-

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
CAS Datenbank
75899 · 75899-68-2(CAS DataBase Reference)
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

Sicherheitsdaten

wgk
WGK 3
Speicherklasse
3 - Flammable liquids
Hazard Classifications
Eye Irrit. 2Flam. Liq. 2
2-Nonenal, 4-[(tetrahydro-2H-pyran-2-yl)oxy]-, (2E)-
(E)-4-hydroxynon-2-enal dimethyl acetal
Methoxymethylenetriphenylphosphorane
1-Octen-3-ol
Brompentylmagnesium
2-Propenal
Hexanal
1-Brompentan

Nachgelagerte Produkte

4-HYDROXY NONENAL MERCAPTURIC ACID